000 01258 a2200349 4500
005 20250512104400.0
264 0 _c19720407
008 197204s 0 0 eng d
022 _a0021-9754
024 7 _a10.1002/j.1552-4604.1972.tb00154.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBiran, S
245 0 0 _aEffect of beta-blocking drug propranolol on 131 I utilization in euthyroid patients.
_h[electronic resource]
260 _bThe Journal of clinical pharmacology and new drugs
_c
300 _a105-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdrenergic beta-Antagonists
_xpharmacology
650 0 4 _aAdult
650 0 4 _aBlood Proteins
_xanalysis
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aIodine
_xblood
650 0 4 _aIodine Isotopes
650 0 4 _aPropranolol
_xadministration & dosage
650 0 4 _aProtein Binding
650 0 4 _aThyroid Gland
_xdrug effects
650 0 4 _aTime Factors
700 1 _aTal, E
773 0 _tThe Journal of clinical pharmacology and new drugs
_gvol. 12
_gno. 2
_gp. 105-7
856 4 0 _uhttps://doi.org/10.1002/j.1552-4604.1972.tb00154.x
_zAvailable from publisher's website
999 _c4405053
_d4405053